Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2011 (2011), Article ID 563204, 2 pages
http://dx.doi.org/10.1155/2011/563204
Case Report

Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy

Department of Psychiatry, Rohilkhand Medical College, Bareilly, Uttar Pradesh 243006, India

Received 6 September 2011; Accepted 4 October 2011

Academic Editor: F. Jollant

Copyright © 2011 Rohit Kant Srivastava et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. APA, Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR) 4, American Psychiatric Publishing, Washington, DC, USA, 2000.
  2. E. Fombonne, R. Zakarian, A. Bennett, L. Meng, and D. McLean-Heywood, “Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations,” Pediatrics, vol. 118, no. 1, pp. e139–e150, 2006. View at Publisher · View at Google Scholar
  3. C. J. Newschaffer, L. A. Croen, J. Daniels et al., “The epidemiology of autism spectrum disorders,” Annual Review of Public Health, vol. 28, pp. 235–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. B. Caronna, J. M. Milunsky, and H. Tager-Flusberg, “Autism spectrum disorders: clinical and research frontiers,” Archives of Disease in Childhood, vol. 93, no. 6, pp. 518–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. E. Levy, D. S. Mandell, and R. T. Schultz, “Autism,” The Lancet, vol. 374, no. 9701, pp. 1627–1638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. K. Perry, M. L. W. Lee, C. M. Martin-Ruiz et al., “Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain,” American Journal of Psychiatry, vol. 158, no. 7, pp. 1058–1066, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Hazell, “Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder,” Journal of Paediatrics and Child Health, vol. 43, no. 1-2, pp. 19–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Y. Hardan and B. L. Handen, “A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 12, no. 3, pp. 237–241, 2002. View at Google Scholar
  9. B. L. Handen, C. R. Johnson, S. McAuliffe-Bellin, P. J. Murray, and A. Y. Hardan, “Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures,” Journal of Child and Adolescent Psychopharmacology, vol. 21, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar
  10. M. G. Chez, T. M. Buchanan, M. Becker, J. Kessler, M. C. Aimonovitch, and S. R. Mrazek, “Donepezil hydrochloride: a double-blind study in autistic children,” Journal of Pediatric Neurology, vol. 1, no. 2, pp. 83–88, 2003. View at Google Scholar
  11. N. R. Dunn, G. L. Pearce, and S. A. W. Shakir, “Adverse effects associated with the use of donepezil in general practice in England,” Journal of Psychopharmacology, vol. 14, no. 4, pp. 406–408, 2000. View at Google Scholar · View at Scopus
  12. B. Roseman, E. Schneider, D. Crimmins et al., “What to measure in autism drug trials,” Journal of Autism and Developmental Disorders, vol. 31, no. 3, pp. 361–362, 2001. View at Publisher · View at Google Scholar